Dr. Jessica Hartman is an Associate Professor in the Department of Biochemistry and Molecular Biology and the Department of Regenerative Medicine at the Medical University of South Carolina. Dr. Hartman completed her Ph.D. with the support of a NSF GRFP fellowship at the University of Arkansas for Medical Sciences in the lab of Dr. Grover Miller studying enzyme kinetics of substrate oxidation by cytochrome P450 2E1 (CYP2E1). She then went on to do a NIEHS F32-supported postdoctoral fellowship with Dr.

Dr. Kleiner obtained an M.D. and Ph.D. (Chemistry) from the University of Chicago. After a residency in Anatomic Pathology at the National Cancer Institute, he joined the faculty of the Laboratory of Pathology in the NCI. He is currently a Senior Research Physician and Chief of the Postmortem Section of the Laboratory of Pathology with expertise in hepatic pathology. His research has focused on chronic liver disease, drug-induced liver injury and liver cancer, with particular attention to assessing histological responses to therapy.

Mitchell R. McGill, PhD, NRCC, FADLM (or just Mitch!) is Associate Professor of Toxicology, Public Health, and Pathology at the University of Arkansas for Medical Sciences. His primary interests are 1) mechanistic and clinical aspects of acetaminophen hepatotoxicity, 2) biomarkers of liver injury for clinical and regulatory applications, and 3) fundamental mechanisms of liver repair.

Dr. Debora Kogan-Liberman is an Associate Professor of Pediatrics in the Division of Pediatric Gastroenterology, Hepatology and Nutrition at the NYU Grossman School of Medicine . She is the Director of Pediatric Hepatology at the Hassenfeld Children's Hospital at NYU Langone Health. Her research interests include cholestatic liver disease in children, Fontan-associated liver disease and pediatric liver transplant.

Andrew Wehrman is a pediatric transplant hepatologist at Boston Children's Hospital. He has research interests in cholestatic liver diseases including Alagille syndrome, biliary atresia, and progressive familial intrahepatic cholestasis.

Dr Alonso is a Pediatric Hepatologist, a clinical and translational researcher and senior leader in health care administration at Lurie Children's Hospital in Chicago. She has been the Medical Director of the Siragusa Transplant Center at Lurie since 2018. Her research portfolio has focused on long-term outcomes following pediatric liver transplantation and the mechanisms of liver injury in acute liver failure.

Saeed Mohammad is a pediatric hepatologist and Medical Director of the Pediatric Solid Organ Transplant Center at Vanderbilt University Medical Center. His research interests include liver transplantation, quality of life in chronic liver disease and autoimmune liver disease

Dr. Amy Taylor completed her medical training at Cincinnati Children's Hospital, where she then continued as an Assistant Professor. She currently serves as the Program Director for the Transplant Hepatology Fellowship. Her research focus is on patient-centered outcomes improvement in pediatric Autoimmune Liver Disease. She serves as the PI for A-LiNK: the Autoimmune Liver disease Network for Kids, a multi-center learning health network.

Dr. Sarah Kemme is an Assistant Professor in Pediatrics at Cincinnati Children's Hospital Medical Center, where she specializes in Pediatric Hepatology and Pediatric Transplant Hepatology. She completed her training at Cincinnati Children's Hospital Medical Center and Children's Hospital Colorado.

Amal Aqul, MD is an Associate Professor of Pediatrics at UT Southwestern Medical Center and serves as Director of Pediatric Hepatology and Medical Director of the Liver Transplant Program at Children's Health Dallas. Her clinical and research interests focus on pediatric liver disease, acute liver failure, cholestatic liver disorders, and liver transplantation. Dr. Aqul is actively involved in national education and leadership through AASLD and NASPGHAN, where she currently chairs the Hepatology Committee and co-directs the NASPGHAN Hepatology Bootcamp.